Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR7280 in Premenopausal Subjects With Endometriosis
NCT04417972Phase 2Completed
- Sponsor
- Hengrui
- Start
- Jul 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHR7280 in endometriosis, sponsored by Hengrui. Started Jul 2020; status: completed.
02
Drugs
SHR7280
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04417972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417972.